Opus Genetics Stock Price History
| IRD Stock | 2.56 0.06 2.40% |
Below is the normalized historical share price chart for Opus Genetics extending back to November 30, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Opus Genetics stands at 2.56, as last reported on the 23rd of January, with the highest price reaching 2.56 and the lowest price hitting 2.47 during the day.
If you're considering investing in Opus Stock, it is important to understand the factors that can impact its price. Opus Genetics appears to be unstable, given 3 months investment horizon. Opus Genetics maintains Sharpe Ratio (i.e., Efficiency) of 0.11, which implies the firm had a 0.11 % return per unit of risk over the last 3 months. By analyzing Opus Genetics' technical indicators, you can evaluate if the expected return of 0.5% is justified by implied risk. Please evaluate Opus Genetics' Semi Deviation of 3.51, risk adjusted performance of 0.0987, and Coefficient Of Variation of 817.04 to confirm if our risk estimates are consistent with your expectations. As of January 23, 2026, Total Stockholder Equity is expected to decline to about 7.3 M. In addition to that, Common Stock Shares Outstanding is expected to decline to about 17.5 M. At present, Opus Genetics' Price To Book Ratio is projected to slightly grow based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 4.47, whereas Price Earnings Ratio is forecasted to decline to (0.67). Opus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 23rd of May 2005 | 200 Day MA 1.4509 | 50 Day MA 2.063 | Beta 0.415 |
Sharpe Ratio = 0.1127
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | IRD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Opus Genetics is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Opus Genetics by adding it to a well-diversified portfolio.
Price Book 27.3915 | Enterprise Value Ebitda (2.55) | Price Sales 11.1225 | Shares Float 37.5 M | Wall Street Target Price 7.7273 |
Opus Genetics Stock Price History Chart
There are several ways to analyze Opus Stock price data. The simplest method is using a basic Opus candlestick price chart, which shows Opus Genetics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 23, 2026 | 2.56 |
| Lowest Price | November 17, 2025 | 1.74 |
Opus Genetics January 23, 2026 Stock Price Synopsis
Various analyses of Opus Genetics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Opus Stock. It can be used to describe the percentage change in the price of Opus Genetics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Opus Stock.| Opus Genetics Price Daily Balance Of Power | 0.67 | |
| Opus Genetics Price Rate Of Daily Change | 1.02 | |
| Opus Genetics Price Action Indicator | 0.07 |
Opus Genetics January 23, 2026 Stock Price Analysis
Opus Stock Price History Data
The price series of Opus Genetics for the period between Sat, Oct 25, 2025 and Fri, Jan 23, 2026 has a statistical range of 0.76 with a coefficient of variation of 7.64. Under current investment horizon, the daily prices are spread out with arithmetic mean of 2.07. The median price for the last 90 days is 2.02. The company completed 1:4 stock split on 6th of November 2020. Opus Genetics completed dividends distribution on 2020-11-06.| Open | High | Low | Close | Volume | ||
01/23/2026 | 2.50 | 2.56 | 2.46 | 2.56 | ||
01/22/2026 | 2.36 | 2.58 | 2.36 | 2.50 | 614,505 | |
| 01/21/2026 | 2.27 | 2.37 | 2.22 | 2.36 | 1,612,047 | |
01/20/2026 | 2.07 | 2.30 | 2.07 | 2.26 | 524,549 | |
| 01/16/2026 | 2.08 | 2.15 | 2.03 | 2.10 | 213,313 | |
01/15/2026 | 2.18 | 2.18 | 2.05 | 2.08 | 170,018 | |
01/14/2026 | 2.14 | 2.26 | 2.06 | 2.17 | 364,898 | |
01/13/2026 | 2.05 | 2.14 | 1.97 | 2.14 | 570,340 | |
| 01/12/2026 | 1.96 | 2.06 | 1.88 | 2.05 | 367,167 | |
| 01/09/2026 | 2.01 | 2.02 | 1.89 | 1.93 | 602,523 | |
01/08/2026 | 2.13 | 2.15 | 1.99 | 2.00 | 434,677 | |
01/07/2026 | 2.06 | 2.17 | 2.04 | 2.11 | 353,017 | |
| 01/06/2026 | 2.12 | 2.16 | 2.05 | 2.08 | 225,693 | |
01/05/2026 | 2.16 | 2.16 | 1.94 | 2.13 | 739,341 | |
01/02/2026 | 2.25 | 2.33 | 2.04 | 2.12 | 833,392 | |
| 12/31/2025 | 1.95 | 2.04 | 1.94 | 2.01 | 214,038 | |
12/30/2025 | 1.99 | 1.99 | 1.94 | 1.95 | 252,330 | |
| 12/29/2025 | 2.00 | 2.03 | 1.93 | 1.99 | 389,522 | |
12/26/2025 | 2.03 | 2.06 | 1.96 | 2.02 | 217,597 | |
12/24/2025 | 2.02 | 2.09 | 1.99 | 2.04 | 148,902 | |
12/23/2025 | 2.06 | 2.06 | 1.96 | 2.01 | 223,090 | |
12/22/2025 | 2.02 | 2.12 | 2.00 | 2.06 | 326,532 | |
12/19/2025 | 1.97 | 2.02 | 1.92 | 2.00 | 442,158 | |
| 12/18/2025 | 2.02 | 2.09 | 1.97 | 1.98 | 313,489 | |
12/17/2025 | 2.17 | 2.19 | 2.01 | 2.02 | 483,170 | |
12/16/2025 | 2.14 | 2.20 | 2.14 | 2.14 | 237,962 | |
12/15/2025 | 2.37 | 2.42 | 2.13 | 2.13 | 358,549 | |
| 12/12/2025 | 2.43 | 2.50 | 2.32 | 2.36 | 334,280 | |
12/11/2025 | 2.53 | 2.53 | 2.41 | 2.44 | 346,891 | |
| 12/10/2025 | 2.49 | 2.59 | 2.45 | 2.50 | 855,351 | |
| 12/09/2025 | 2.29 | 2.48 | 2.27 | 2.39 | 4,646,845 | |
12/08/2025 | 2.28 | 2.32 | 2.21 | 2.29 | 191,540 | |
12/05/2025 | 2.25 | 2.29 | 2.14 | 2.27 | 224,173 | |
12/04/2025 | 2.09 | 2.29 | 2.06 | 2.23 | 382,855 | |
12/03/2025 | 2.03 | 2.12 | 1.99 | 2.09 | 263,570 | |
12/02/2025 | 2.00 | 2.06 | 1.97 | 1.99 | 410,407 | |
12/01/2025 | 2.11 | 2.11 | 1.97 | 2.00 | 221,985 | |
11/28/2025 | 2.04 | 2.15 | 2.03 | 2.13 | 265,145 | |
11/26/2025 | 2.01 | 2.05 | 1.98 | 2.02 | 256,373 | |
11/25/2025 | 2.03 | 2.03 | 1.92 | 1.98 | 305,499 | |
11/24/2025 | 1.94 | 2.01 | 1.94 | 2.00 | 246,867 | |
11/21/2025 | 1.93 | 1.95 | 1.86 | 1.91 | 162,707 | |
| 11/20/2025 | 1.88 | 2.05 | 1.87 | 1.93 | 764,876 | |
11/19/2025 | 1.88 | 1.91 | 1.80 | 1.86 | 460,300 | |
11/18/2025 | 1.72 | 1.89 | 1.70 | 1.88 | 420,818 | |
11/17/2025 | 1.85 | 1.91 | 1.74 | 1.74 | 494,962 | |
11/14/2025 | 1.83 | 1.93 | 1.80 | 1.88 | 382,885 | |
11/13/2025 | 1.96 | 1.98 | 1.78 | 1.85 | 623,488 | |
11/12/2025 | 1.92 | 1.95 | 1.85 | 1.92 | 417,480 | |
11/11/2025 | 1.96 | 1.98 | 1.85 | 1.97 | 659,000 | |
11/10/2025 | 2.03 | 2.03 | 1.92 | 1.97 | 614,755 | |
11/07/2025 | 2.04 | 2.08 | 1.88 | 2.00 | 663,616 | |
11/06/2025 | 2.04 | 2.13 | 1.86 | 2.03 | 1,405,076 | |
| 11/05/2025 | 2.17 | 2.22 | 2.12 | 2.12 | 250,834 | |
11/04/2025 | 2.10 | 2.23 | 2.03 | 2.17 | 471,479 | |
11/03/2025 | 2.32 | 2.37 | 2.10 | 2.14 | 561,227 | |
10/31/2025 | 2.01 | 2.30 | 1.96 | 2.30 | 1,264,095 | |
10/30/2025 | 1.98 | 2.01 | 1.90 | 1.97 | 450,156 | |
10/29/2025 | 1.96 | 2.04 | 1.90 | 1.98 | 892,022 | |
10/28/2025 | 2.00 | 2.02 | 1.90 | 1.93 | 303,604 | |
10/27/2025 | 1.97 | 2.02 | 1.95 | 2.00 | 342,067 |
About Opus Genetics Stock history
Opus Genetics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Opus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Opus Genetics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Opus Genetics stock prices may prove useful in developing a viable investing in Opus Genetics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 30.7 M | 17.5 M |
Opus Genetics Quarterly Net Working Capital |
|
Opus Genetics Stock Technical Analysis
Opus Genetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
| All Next | Launch Module |
Opus Genetics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Opus Genetics' price direction in advance. Along with the technical and fundamental analysis of Opus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Opus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0987 | |||
| Jensen Alpha | 0.4801 | |||
| Total Risk Alpha | (0.03) | |||
| Sortino Ratio | 0.1105 | |||
| Treynor Ratio | 1.16 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Opus Stock analysis
When running Opus Genetics' price analysis, check to measure Opus Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opus Genetics is operating at the current time. Most of Opus Genetics' value examination focuses on studying past and present price action to predict the probability of Opus Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opus Genetics' price. Additionally, you may evaluate how the addition of Opus Genetics to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |